Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis

Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis

Background: Proton pump inhibitors (PPIs) are usually prescribed to prevent gastrointestinal (GI) complications in patients receiving dual antiplatelet therapy (DAPT). This systematic review and meta-analysis aimed to explore the efficacy and safety of the concomitant use of PPIs with aspirin-clopid...

Full description

Bibliographic Details
Main Authors: Xiaofeng Luo, Min Hou, Shuangshuang He, Xue Yang, Pan Zhang, Yingxin Zhao, Haiyan Xing
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Pharmacology
Subjects:
proton pump inhibitors
aspirin
clopidogrel
coronary heart disease
medication interaction
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1021584/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.1021584/full

Similar Items